A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
Clinical trial NCT02453685 · COMPLETED
Trial details
- NCT number
- NCT02453685
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-31
- Primary completion
- 2016-09-20
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.